Company Overview
About Maze Therapeutics
Maze Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 by Charles Homcy and headquartered in South San Francisco, California, that uses human genetics as its primary drug discovery engine. The company's approach begins with population-scale genetic data to identify individuals who are naturally protected from diseases like chronic kidney disease (CKD), obesity, and cardiovascular disorders — then designs small-molecule drugs that mimic the protective genetic effect in the broader patient population. This genetics-first model is designed to increase the probability of clinical success by targeting validated mechanisms with demonstrated human proof of concept before any clinical trial begins.
Business Model & Competitive Advantage
Maze's lead programs include MZE829 and MZE782, both targeting chronic kidney disease — one of the largest unmet needs in medicine, affecting roughly 37 million Americans and associated with high cardiovascular mortality and rapid progression to dialysis. The company is also exploring precision approaches for obesity and metabolic diseases, where genetic stratification could identify patient subgroups most likely to respond. Maze has raised over $290M in total funding from investors including GV (Google Ventures), Casdin Capital, Foresite Capital, and ARCH Venture Partners — a high-pedigree investor base reflecting confidence in its genetic discovery platform.
Competitive Landscape 2025–2026
Maze Therapeutics differentiates from traditional biotech drug discovery through the scale and rigor of its genetic analysis infrastructure. The company's platform integrates large-scale human genetic datasets (biobanks, GWAS studies, whole-exome sequencing) with functional genomics and medicinal chemistry to move from genetic signal to drug candidate with greater speed and confidence. This positions Maze alongside other genetics-driven biotechs like Goldfinch Bio and Verve Therapeutics, but with a broader multi-disease focus anchored to renal and metabolic health.
Key Differentiators
Emerging Innovator
Maze Therapeutics is an emerging player bringing innovative solutions to the Life Sciences & BioTech market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare Maze Therapeutics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Maze Therapeutics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Maze Therapeutics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Maze Therapeutics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →